CD34 and Alzheimer disease: In this context we recommend, for future mechanistic investigations, the evaluation of graft composition (all T and B naive and memory subsets, regulatory T and B cell subsets, autoreactive cells) after CD34+ cell mobilization for each transplanted AD disease, as well as its correlation with clinical outcomes.